Moderna (MRNA) Other Working Capital Changes (2018 - 2026)
Moderna (MRNA) posted quarterly Other Working Capital Changes of $50.0 million for Q2 2026, down 48.45% year-over-year from $97.0 million in Q2 2025, and up 814.29% on a QoQ basis from -$7.0 million in Q1 2026.
Moderna (MRNA) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Moderna has reported Other Working Capital Changes for 9 years, with the latest figure at $50.0 million in Q2 2026.
- Other Working Capital Changes for Q2 2026 came in at $50.0 million, down 48.45% year-over-year; the trailing twelve-month figure through Jun 2026 was $16.0 million (up 103.09% YoY), and the FY2025 annual result was $41.0 million, up 109.34% from the prior year.
- Other Working Capital Changes improved to $50.0 million in Q2 2026, from -$7.0 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.6 billion in Q4 2022 and troughed at -$1.0 billion in Q4 2023.
- A 5-year average of $5.2 million and a median of -$46.0 million in 2025 frame the typical range for Other Working Capital Changes.
- The widest annual swing landed in 2022, when Other Working Capital Changes slumped 571.67%; it then soared 211.88% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$1.5 billion in 2022, then soared by 39.5% to -$887.0 million in 2023, then surged by 70.46% to -$262.0 million in 2024, then soared by 74.43% to -$67.0 million in 2025, then soared by 174.63% to $50.0 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $50.0 million in Q2 2026, -$7.0 million in Q1 2026, and -$67.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.00 Mn |
| Jun 30, 2026 | -16.00 Mn |
| Jun 30, 2026 | -16.00 Mn |
| Mar 31, 2026 | -54.00 Mn |
| Mar 31, 2026 | -54.00 Mn |
| Mar 31, 2026 | -54.00 Mn |
| Dec 31, 2025 | -237.00 Mn |
| Dec 31, 2025 | -237.00 Mn |
| Dec 31, 2025 | -237.00 Mn |
| Sep 30, 2025 | -66.00 Mn |
| Sep 30, 2025 | -66.00 Mn |
| Sep 30, 2025 | -66.00 Mn |
| Jun 30, 2025 | 196.00 Mn |
| Jun 30, 2025 | 196.00 Mn |
| Jun 30, 2025 | 196.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Mar 31, 2025 | -46.00 Mn |
| Dec 31, 2024 | -292.00 Mn |
| Dec 31, 2024 | -292.00 Mn |